Cytheris
Issy-les-moulineaux
About Cytheris
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $10K – $50K
- Total funding: $48.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Jun 2010)
- Website: cytheris.com
- Phone: 33-(0)-1-5888-3800
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/cytheris-1015951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.